Poll Shows 27% Of European Adults Likely To Refuse Vaccine In Latest Threat To Growth Outlook
Francesco Abbruzzino, The Uncensored Report, LLC
After getting off to a rocky start, Europe’s vaccination campaign has accelerated in recent weeks, despite lingering restrictions on the continent’s “workhorse” AstraZeneca jab (over concerns about deadly cerebral blood clots that have affected a small number of patients with low blood-platelet counts), and lingering skepticism among many younger people, including health-care workers.
According to the latest numbers from Bloomberg, more than 1.36 billion doses of various vaccines have been administered (though this figure likely leaves out many millions who have been vaccinated in China) and of these, EU countries have administered just over 200M. Still, only 12% of European adults have been fully vaccinated, and that number has been rising with agonizing slowness.
And as the US prepares to start vaccinating children as young as 12, vaccine skepticism remains a major long-term obstacle to Europe’s long-term growth outlook, which is becoming an increasingly important piece of many investors’ outlook for an expected sharp rebound in global growth over the coming year as the developed world emerges from the COVID era.
